Goldman Sachs & Co. LLC
200 West Street
New York, New York 10282
Morgan Stanley & Co. LLC
1585 Broadway
New York, New York 10036
J.P. Morgan Securities LLC
383 Madison Avenue
New York, New York 10179
December 4, 2017
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
Office of Healthcare & Insurance
100 F Street, N.E.
Washington, D.C. 20549-3720
Attention: | Chris Edwards |
Erin Jaskot |
Keira Nakada |
Jim Rosenberg |
Re: | Denali Therapeutics Inc. |
Registration Statement on Form S-1 |
File No. 333-221522 |
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended (the Act), we, as representatives of the several underwriters, hereby join in the request of Denali Therapeutics Inc. (the Company) for acceleration of the effective date of the above-named Registration Statement so that it will be declared effective at 4:00 PM, Eastern Time, on December 7, 2017, or as soon thereafter as practicable, or at such other time as the Company or its outside counsel, Wilson Sonsini Goodrich & Rosati, Professional Corporation, request by telephone that such Registration Statement be declared effective.
Pursuant to Rule 460 under the Act, we, as representatives of the several underwriters, wish to advise you that we have effected the following distribution of the Companys preliminary prospectus dated November 27, 2017:
(i) | Dates of distribution: November 27, 2017 through the date hereof |
(ii) | Number of prospective underwriters to which the preliminary prospectus was furnished: 4 |
(iii) | Number of prospectuses furnished to investors: approximately 2,479 |
(iv) | Number of prospectuses distributed to others, including the Company, the Companys counsel, independent accountants, and underwriters counsel: approximately 145 |
The undersigned advise that they have complied and will continue to comply, and each underwriter and dealer has advised the undersigned that it has complied and will continue to comply, with Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
[Signature page follows]
* * * *
Very truly yours, | ||||
GOLDMAN SACHS & CO. LLC MORGAN STANLEY & CO. LLC J.P. MORGAN SECURITIES LLC | ||||
Acting severally on behalf of themselves and the several underwriters | ||||
GOLDMAN SACHS & CO. LLC | ||||
By: | /s/ Goldman Sachs & Co. | |||
Name: | Gabe Gelman | |||
Title: | Managing Director | |||
MORGAN STANLEY & CO. LLC | ||||
By: | /s/ Kalli Dircks | |||
Name: | Kalli Dircks | |||
Title: | Vice President | |||
J.P. MORGAN SECURITIES LLC | ||||
By: | /s/ Ben Burdett | |||
Name: | Ben Burdett | |||
Title: | Executive Director |
[Signature Page to Underwriters Acceleration Request]